Agnieszka Szeremet

Ibrutinib discontinuation in patients with relapsed or refractory chronic lymphocytic leukemia treated in a compassionate use program: A report from the Polish Adult Leukemia Study Group (PALG).

J. Zaucha, K. Warzocha, B. Puła, 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

J. Zaucha, T. Robak, K. Giannopoulos, 2017, Leukemia & lymphoma.

Results of Polish Adult Leukemia Study Group (PALG) project assessing TP53 mutations with next-generation sequencing technology in relapsed and refractory chronic lymphocytic leukemia patients — an 18-month update

R. Płoski, M. Rydzanicz, T. Stokłosa, 2021, Acta Haematologica Polonica.

Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.

J. Zaucha, K. Giannopoulos, A. Pasternak, 2019, Advances in medical sciences.

Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group.

S. Szmit, J. Drozd-Sokołowska, M. Joks, 2024, Heart, lung & circulation.

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia

M. Gajewska, K. Giannopoulos, J. Drozd-Sokołowska, 2022, Cancers.

The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a “real‐world” study: Polish Myeloma Group experience

P. Bernatowicz, A. Dmoszyńska, R. Guzicka-Kazimierczak, 2018, European journal of haematology.

Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group

P. Boguradzki, A. Waszczuk-Gajda, E. Snarski, 2024, Cancers.

Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors

L. Szenborn, A. Czyż, T. Wróbel, 2022, Cancers.